Jonathan Martinez-Pinto

Dr. Jonathan Martinez-Pinto

Institute of Physiology, University of Valparaíso, Valparaíso, Chile
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2019 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
CGCamila González-Arancibia
Camila González-Arancibia
JUJocelyn Urrutia-Piñones
Jocelyn Urrutia-Piñones
JIJaviera Illanes-González
Javiera Illanes-González
Jonathan Martinez-PintoJonathan Martinez-Pinto
Jonathan Martinez-Pinto
Ramón Sotomayor-ZárateRamón Sotomayor-Zárate
Ramón Sotomayor-Zárate
JBJAVIER BRAVO
JAVIER BRAVO

Verified
Journal Article
Open access
PDF file
José Luis Marcos CamusJosé Luis Marcos Camus
José Luis Marcos Camus
RORossy Olivares-Barraza
Rossy Olivares-Barraza
KCKarina Ceballo
Karina Ceballo
MWMelisa Wastavino
Melisa Wastavino
VOVíctor Ortiz
Víctor Ortiz
Ramón Sotomayor-ZárateRamón Sotomayor-Zárate
Ramón Sotomayor-Zárate
Obesity-induced neuroinflammation is a chronic aseptic central nervous system inflammation that presents systemic characteristics associated with increased pro-inflammatory cytokines such as interleukin 1 beta (IL-1β) and interleukin 18 (IL-18) and the presence of microglia and reactive astrogliosis as well as the activation of the NLRP3 inflammasome. The obesity pandemic is associated with lifestyle changes, including an excessive intake of obesogenic foods and decreased physical activity. Brain areas such as the lateral hypothalamus (LH), lateral septum (LS), ventral tegmental area (VTA), and nucleus accumbens (NAcc) have been implicated in the homeostatic and hedonic control of feeding in experimental models of diet-induced obesity. In this context, a chronic lipid intake triggers neuroinflammation in several brain regions such as the hypothalamus, hippocampus, and amygdala. This review aims to present the background defining the significant impact of neuroinflammation and how this, when induced by an obesogenic diet, can affect feeding control, triggering metabolic and neurological alterations.

Verified
Journal Article
Open access
PDF file
AEAngelica Escobar
Angelica Escobar
CBChristian Bonansco
Christian Bonansco
GCGonzalo Cruz
Gonzalo Cruz
ADAlexies Dagnino-Subiabre
Alexies Dagnino-Subiabre
MFMarco Fuenzalida
Marco Fuenzalida
GJGonzalo Jorquera
Gonzalo Jorquera
Many diseases and degenerative processes affecting the nervous system and peripheral organs trigger the activation of inflammatory cascades. Inflammation can be triggered by different environmental conditions or risk factors, including drug and food addiction, stress, and aging, among others. Several pieces of evidence show that the modern lifestyle and, more recently, the confinement associated with the COVID-19 pandemic have contributed to increasing the incidence of addictive and neuropsychiatric disorders, plus cardiometabolic diseases. Here, we gather evidence on how some of these risk factors are implicated in activating central and peripheral inflammation contributing to some neuropathologies and behaviors associated with poor health. We discuss the current understanding of the cellular and molecular mechanisms involved in the generation of inflammation and how these processes occur in different cells and tissues to promote ill health and diseases. Concomitantly, we discuss how some pathology-associated and addictive behaviors contribute to worsening these inflammation mechanisms, leading to a vicious cycle that promotes disease progression. Finally, we list some drugs targeting inflammation-related pathways that may have beneficial effects on the pathological processes associated with addictive, mental, and cardiometabolic illnesses.

26 March 2019 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
VVVictoria B. Velásquez
Victoria B. Velásquez
GZGabriel A. Zamorano
Gabriel A. Zamorano
Jonathan Martinez-PintoJonathan Martinez-Pinto
Jonathan Martinez-Pinto
CBChristian Bonansco
Christian Bonansco
PJPablo Jara
Pablo Jara
Ramón Sotomayor-ZárateRamón Sotomayor-Zárate
Ramón Sotomayor-Zárate
Neonatal programming with sex hormones produces long-term functional changes in various tissues, including the brain. Previously, we demonstrated a higher content of dopamine and an increase in potassium-induced dopamine release in the nucleus accumbens of adult rats exposed to estradiol valerate. On the other hand, sex hormones also affect the opioid system increasing the expression of the μ opioid receptor and β-endorphins. Here, we investigated if neonatal programming with sex hormones alters the response to morphine during adulthood in rats and predispose them to neurochemical, rewarding and behavioral activating effects. We examined the effects of neonatal exposure to a single dose of estradiol valerate or testosterone propionate on morphine-induced (5 mg/kg, i.v.) dopamine release in the nucleus accumbens and morphine-induced (3 mg/kg, s.c.) locomotor activity and conditioned place preference when these rats were adults. Our results showed a significant increase in morphine-induced dopamine release in the nucleus accumbens of rats that were exposed neonatally to estradiol compared with control rats. This effect was correlated with higher place preference and locomotor activity induced by morphine in adult rats neonatally exposed to estradiol valerate. However, the effect of morphine on dopamine release and behaviors was similar in rats treated with testosterone compared to control rats. Additionally, the expression of mu (μ) opioid receptor, dopamine receptor type 1 (D1) and dopamine receptor type 2 (D2) in the nucleus accumbens of adult rats was not different after treatment with sex hormones. Taken together, our results demonstrated an enhancement of pharmacological effects produced by morphine in rats neonatally programmed with estradiol valerate, suggesting that early exposure to sex hormones could represent a vulnerability factor in the development of addiction to opioid drugs such as morphine and heroin in adulthood.

29 January 2018 in Journal of Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
CBC. Bonansco
C. Bonansco
Jonathan Martinez-PintoJonathan Martinez-Pinto
Jonathan Martinez-Pinto
RSR. A. Silva
R. A. Silva
VVV. B. Velásquez
V. B. Velásquez
AMA. Martorell
A. Martorell
Ramón Sotomayor-ZárateRamón Sotomayor-Zárate
Ramón Sotomayor-Zárate

Verified
Journal Article
Open access
PDF file
WPWladimir Plaza-Briceño
Wladimir Plaza-Briceño
VVVictoria B. Velásquez
Victoria B. Velásquez
FSFrancisco Silva-Olivares
Francisco Silva-Olivares
KCKarina Ceballo
Karina Ceballo
RCRicardo Céspedes
Ricardo Céspedes
Ramón Sotomayor-ZárateRamón Sotomayor-Zárate
Ramón Sotomayor-Zárate
Obesity is a pandemic caused by many factors, including a chronic excess in hypercaloric and high-palatable food intake. In addition, the global prevalence of obesity has increased in all age categories, such as children, adolescents, and adults. However, at the neurobiological level, how neural circuits regulate the hedonic consumption of food intake and how the reward circuit is modified under hypercaloric diet consumption are still being unraveled. We aimed to determine the molecular and functional changes of dopaminergic and glutamatergic modulation of nucleus accumbens (NAcc) in male rats exposed to chronic consumption of a high-fat diet (HFD). Male Sprague-Dawley rats were fed a chow diet or HFD from postnatal day (PND) 21 to 62, increasing obesity markers. In addition, in HFD rats, the frequency but not amplitude of the spontaneous excitatory postsynaptic current is increased in NAcc medium spiny neurons (MSNs). Moreover, only MSNs expressing dopamine (DA) receptor type 2 (D2) increase the amplitude and glutamate release in response to amphetamine, downregulating the indirect pathway. Furthermore, NAcc gene expression of inflammasome components is increased by chronic exposure to HFD. At the neurochemical level, DOPAC content and tonic dopamine (DA) release are reduced in NAcc, while phasic DA release is increased in HFD-fed rats. In conclusion, our model of childhood and adolescent obesity functionally affects the NAcc, a brain nucleus involved in the hedonic control of feeding, which might trigger addictive-like behaviors for obesogenic foods and, through positive feedback, maintain the obese phenotype.